PT-141 represents a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound operates by stimulating specific receptors across the body, causing to improved sexual performance. Preclinical studies have suggested that PT-141 may effectively treat a range of sexual dysfunctions